Literature DB >> 27605680

Risk Factors for Decline of Residual Renal Function in Children Treated With Peritoneal Dialysis.

Maria Roszkowska-Blaim1, Piotr Skrzypczyk2.   

Abstract


BACKGROUND: The aim of the study was to assess risk factors for residual renal function (RRF) decline in children during the first/second year of chronic peritoneal dialysis (PD). ♦
METHODS: The study group included 56 children with end-stage renal disease (ESRD) (age 10.13 ± 4.86 years), including 18 on continuous ambulatory PD (CAPD) and 38 on automated PD (APD), in whom we evaluated RRF (daily diuresis [mL/m2/24 h], residual glomerular filtration rate (rGFR) [mL/min/1.73 m2]), etiology of ESRD, PD fluid volume (mL/m2/24 h), glucose load (g/m2/24 h), ultrafiltration (mL/m2/24 h), peritoneal permeability (D/PCrea 4h, D/D0 Glu 4h), dialysis adequacy (twKt/V, twCCr [L/week/1.73 m2]), blood pressure (BP), biochemical parameters, and medications used. Duration of follow-up was 24 months. ♦
RESULTS: Mean diuresis before initiation of PD was 1,394.93 ± 698.37 (mL/m2/24 h), and mean rGFR was 7.41 ± 3.96 (mL/min/1.73 m2). The rate of daily diuresis decline was -529.34 ± 546.28 in the first year and -107.10 ± 291.54 (mL/m2/24 h) in the second year (p = 0.005), and the rate of rGFR decline was -3.35 ± 3.73 in the first year and -1.63 ± 1.85 (mL/min/1.73 m2) in the second year (p = 0.118). Eleven (19.64%) patients became anuric. In univariate analysis, the rate of daily diuresis decline in the first year was related to baseline diuresis (r = -0.29, p = 0.031), proteinuria (r = -0.43, p = 0.001), and systolic BP (r = -0.31, p = 0.020); 12-month changes (Δ0 - 12) in PD fluid volume (r = -0.37, p = 0.004), glucose load (r = -0.28, p = 0.035), and ultrafiltration (r = -0.38, p = 0.004); serum calcium-phosphorus product (r = -0.41, p = 0.002); and Δ0 - 12 body mass index (BMI) Z-score (r = 0.30, p = 0.024); while the rate of rGFR decline in the first year was related only to baseline rGFR (r = -0.57, p < 0.001). In multivariate analysis, significant predictors of the rate of daily diuresis decline in the first year were baseline diuresis (β = -0.386, p < 0.001) and proteinuria (β = -0.278, p = 0.017), mean systolic BP Z-score (β = -0.237, p = 0.027), and age at the onset of PD (β = -0.224, p = 0.037), while predictors of the rate of rGFR decline were baseline rGFR (β = -0.607, p < 0.001) and baseline proteinuria (β = -0.225, p = 0.046). In the second year, the only predictors of the rate of rGFR decline were D/D0 Glu 4h (r = 0.44, p = 0.033, univariate analysis) and rGFR at 12 months (β = -0.499, p = 0.044). ♦
CONCLUSION: The most important risk factors for rapid RRF decline in children during the first year of chronic PD include higher baseline daily diuresis and proteinuria, and additional factors are systolic BP and age at the onset of PD; while high baseline GFR and low peritoneal transport status may be the only important factors during the second year.
Copyright © 2016 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Residual renal function; children; peritoneal dialysis

Mesh:

Year:  2016        PMID: 27605680      PMCID: PMC5174875          DOI: 10.3747/pdi.2014.00123

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  26 in total

1.  Effects of automated peritoneal dialysis on residual daily urinary volume in children.

Authors:  M Fischbach; J Terzic; S Menouer; K Soulami; C Dangelser; A Helmstetter; F Gehant
Journal:  Adv Perit Dial       Date:  2001

2.  Acute effects of high-dose furosemide on residual renal function in CAPD patients.

Authors:  Rudolf W van Olden; Henk-Jan Guchelaar; Dirk G Struijk; Raymond T Krediet; Lambertus Arisz
Journal:  Perit Dial Int       Date:  2003 Jul-Aug       Impact factor: 1.756

3.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

4.  A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration.

Authors:  Constantin J Konings; Jeroen P Kooman; Ulrich Gladziwa; Frank M van der Sande; Karel M Leunissen
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

5.  Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patients.

Authors:  Chia-Te Liao; Chih-Chung Shiao; Jenq-Wen Huang; Kuan-Yu Hung; Hsueh-Fang Chuang; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai
Journal:  Perit Dial Int       Date:  2008-06       Impact factor: 1.756

6.  Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it.

Authors:  M K Singhal; S Bhaskaran; E Vidgen; J M Bargman; S I Vas; D G Oreopoulos
Journal:  Perit Dial Int       Date:  2000 Jul-Aug       Impact factor: 1.756

7.  Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.

Authors:  Sing Leung Lui; Suk Wai Cheng; Flora Ng; Suk Yi Ng; Kit Mui Wan; Terence Yip; Kai Chung Tse; Man Fai Lam; Kar Neng Lai; Wai Kei Lo
Journal:  Kidney Int       Date:  2005-11       Impact factor: 10.612

8.  Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients.

Authors:  Kook-Hwan Oh; Ju-Young Moon; Jieun Oh; Seong Gyun Kim; Young-Hwan Hwang; Suhnggwon Kim; Jung Sang Lee; Curie Ahn
Journal:  Nephrol Dial Transplant       Date:  2008-01-04       Impact factor: 5.992

9.  Assessment of cardiovascular risk in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.

Authors:  Sevcan A Bakkaloglu; Arda Saygili; Lale Sever; Aytul Noyan; Sema Akman; Mesiha Ekim; Nejat Aksu; Beyza Doganay; Nurdan Yildiz; Ali Duzova; Alper Soylu; Harika Alpay; Ferah Sonmez; Mahmut Civilibal; Sevcan Erdem; Firat Kardelen
Journal:  Nephrol Dial Transplant       Date:  2009-06-18       Impact factor: 5.992

10.  Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD.

Authors:  Hiromichi Suzuki; Yoshihiko Kanno; Soichi Sugahara; Hirokazu Okada; Hidetomo Nakamoto
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.